BPSG
CELG

Brookfield Public Securities Group’s Celgene Corp CELG Stock Holding History

Brookfield Public Securities Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-360,000
Closed -$35.7M – 223
2019
Q3 		$35.7M Buy
+360,000
New +$34.2M 0.35% 69

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Brookfield Public Securities Group's CELG Position: Q4 2019 in Review

Brookfield Public Securities Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 360,000 shares — an estimated $35.7M sold.

Brookfield Public Securities Group first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $35.7M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brookfield Public Securities Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brookfield Public Securities Group sold 360,000 Celgene Corp shares in Q4 2019, an estimated $35.7M.
  • Brookfield Public Securities Group first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
  • Brookfield Public Securities Group's Celgene Corp position peaked at $35.7M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brookfield Public Securities Group's 13F filing for Q4 2019, filed 14 Feb 2020.